Annual Drug Patent Expirations for TWINJECT+0.3
Twinject 0.3 is a drug marketed by Impax and is included in one NDA. It is available from four suppliers. There are two patents protecting this drug.
This drug has forty-three patent family members in fifteen countries.
The generic ingredient in TWINJECT 0.3 is epinephrine. Four suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
